Akèy › Kansè orofaringe
Etid klinik pou Kansè orofaringe ap rekrite nan Etazini
52 etid pou Kansè orofaringe ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Edison, NJ8 etid
- Atlanta, GA8 etid
- Chicago, IL7 etid
- New York City, NY6 etid
- Queens, NY5 etid
- Pittsburgh, PA5 etid
- Milwaukee, WI5 etid
- Omaha, NE5 etid
- Philadelphia, PA5 etid
- Kansas City, MO5 etid
- Los Angeles, CA5 etid
- St. Louis, MO5 etid
- Houston, TX5 etid
- Tampa, FL5 etid
- Rochester, MN4 etid
- East Norwalk, CT4 etid
- Greenburgh, NY4 etid
- Staten Island, NY4 etid
- Kansas City, KS4 etid
- Naperville, IL4 etid
- Detroit, MI4 etid
- Ann Arbor, MI4 etid
- Durham, NC4 etid
- Overland Park, KS4 etid
- Washington, DC4 etid
- Richmond, VA4 etid
- Baltimore, MD4 etid
- New Rochelle, NY3 etid
- West Bend, WI3 etid
- Oklahoma City, OK3 etid
- Champaign, IL3 etid
- Charleston, IL3 etid
- Des Moines, IA3 etid
- Danville, IL3 etid
- Portland, OR3 etid
- Stevens Point, WI3 etid
- Joliet, IL3 etid
- Peoria, IL3 etid
- Bloomington, IL3 etid
- Wausau, WI3 etid
Pa eta
- Arizona4 etid
- Colorado4 etid
- Distrik Columbia3 etid
- Florid12 etid
- Georgia8 etid
- Illinois8 etid
- Iowa5 etid
- Kalifòni9 etid
- Kansas5 etid
- Kentucky3 etid
- Maryland7 etid
- Massachusetts4 etid
- Michigan6 etid
- Minnesota6 etid
- Missouri9 etid
- Nebraska5 etid
- New Hampshire3 etid
- New Jersey8 etid
- New York11 etid
- North Carolina6 etid
- North Dakota3 etid
- Ohio8 etid
- Oklahoma4 etid
- Oregon3 etid
- Pennsylvania10 etid
- South Carolina3 etid
- Tennessee3 etid
- Texas6 etid
- Vermont3 etid
- Virginia4 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05541016Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07195734Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
Ap rekrite
Laj 65 a 99 · Tout sèks · Mizajou Sep 29, 2026 · NCT06309225BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06305676Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05172245Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05880797Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Ap rekriteFaz 2
Laj 22 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT04900623Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06254911Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06445114Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766The Minimalist Trial-2
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06702033Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT05388773Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06662058pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT05799144Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT01365169Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07178301SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05451004Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT04151082E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT05686226Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.